Escalon Medical Corp. ESMC
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 569.04% | 774.18% | -60.28% | -645.03% | -382.59% |
| Total Depreciation and Amortization | -65.12% | -65.91% | -15.15% | -22.64% | -55.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4,220.78% | -9,494.59% | -32.48% | -189.65% | -165.89% |
| Change in Net Operating Assets | -326.38% | 345.49% | -1,925.45% | 1,695.47% | 177.51% |
| Cash from Operations | -1,689.87% | 815.31% | -271.95% | 155.26% | 104.65% |
| Capital Expenditure | 100.00% | -- | -- | -- | 57.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -541.03% | -- | -- | -- | 57.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 86.96% | -879.61% | -1,075.00% | 15.87% | -6.15% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 86.96% | -879.61% | -75.00% | 15.87% | -6.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5,642.00% | 14,630.88% | -283.88% | 238.16% | 101.41% |